Tag Archives: diabetes
Big time losers and the reasons why (TRGT, XIDE, AMLN)
In this report: Targacept Inc. (NASDAQ:TRGT), Exide Technologies (NASDAQ:XIDE) and Amylin Pharmaceuticals (NASDAQ:AMLN).
Targacept Inc. (NASDAQ:TRGT) has dropped by over 56 percent today after the company announced that its experimental drug TC-5214 failed to meet expectations in a trial to …
Posted in Main Post, Reports
Tagged AMLN, Amylin Pharmaceuticals, clinical trial, company, diabetes, drug, Eli Lilly and Co (NYSE:LLY), Exide Technologies, expectations, fiscal, guidance, NASDAQ, NASDAQ:AMLN, NASDAQ:TRGT, NASDAQ:XIDE, net sales, operating income, partnership, patients, payments, Phase 3, preliminary, products, quarter, results, revenue, severe depression, Targacept Inc., therapy, treat, TRGT, trial, XIDA
Comments Off
4 stocks to watch (PNM, MNKD, YOKU, RDS-A)
In this report: PNM Resources (NYSE:PNM), MannKind Corp. (NASDAQ:MNKD), Royal Dutch Shell (NYSE:RDS-A) and Youku.com Inc. (NYSE:YOKU).
PNM Resources (NYSE:PNM) is trading more than 16.9 percent higher today after the company announced that it will sell its competitive business in …
Posted in Latest Headlines
Tagged Afrezza, analyst, Analysts, Benchmark comapny, business, capital, cash, clinical trials, company, deal, diabetes, Direct Energy, drug, earnings, firm, First Choice, forecast, Hold, insulin, MannKind Corp., MNKD, NASDAQ, NASDAQ:MNKD, Neutral, notes, NYSE, NYSE:PNM, NYSE:RDS-A, NYSE:YOKU, outlook, patients, PNM, PNM Resources, positive, Power Business, profitibility, profits, raise, rating, Royal Dutch Shell, sell, senior secured, stock, Susquehanna, trading, utilities, working capital, YOKU, Youku.com Inc.
Comments Off
